Fabry nephropathy: 5 years of enzyme replacement therapy-a short review

NDT Plus. 2008 Feb;1(1):11-19. doi: 10.1093/ndtplus/sfm022. Epub 2007 Dec 19.

Authors

Frédéric Barbey¹, Olivier Lidove², Andreas Schwarting³

Affiliations

¹ Service of Transplantation and Department of Nephrology, Centre Hospitalier Universitaire Vaudois and Lausanne University, Switzerland.
² Department of Internal Medicine, Faculté de Médecine Xavier Bichat, Bichat Hospital, Université Paris 7, Paris, France.
³ Department of Nephrology, University of Mainz, Mainz, Germany.

No abstract available

Keywords: ACE inhibitors; Fabry disease; angiotensin receptor blockers; enzyme replacement therapy; kidney; nephropathy.

Publication types

Editorial